Bank of Montreal
LABU icon

Bank of Montreal’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bank of Montreal’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12
Closed -$1.59K – 3774
2024
Q3 		$1.59K Buy
+12
New +$1.57K ﹤0.01% 3770
2023
Q3 		– Sell
-19
Closed -$2.58K – 4042
2023
Q2 		$2.58K Hold
19
– – ﹤0.01% 3882
2023
Q1 		$1.85K Hold
19
– – ﹤0.01% 3713
2022
Q4 		$2.66K Buy
+19
New +$2.65K ﹤0.01% 3877
2019
Q1 		– Sell
-38
Closed -$25K – 4537
2018
Q4 		$25K Buy
+38
New +$39.8K ﹤0.01% 3562
2018
Q2 		– Sell
-108
Closed -$172K – 4800
2018
Q1 		$172K Buy
108
+60
+125% +$112K ﹤0.01% 2698
2017
Q4 		$74K Buy
+48
New +$73.5K ﹤0.01% 3122

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Bank of Montreal's LABU Position: Q4 2024 in Review

Bank of Montreal sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2024, closing a stake of 12 shares — an estimated $1.59K sold.

Bank of Montreal first reported a position in LABU in Q4 2017 and held it in 7 quarters. The position peaked at $172K in Q1 2018. 37 funds tracked by Wall St. Rank hold LABU as of Q4 2024.

  • Bank of Montreal reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 12 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2024, an estimated $1.59K.
  • Bank of Montreal first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and held it in 7 quarters.
  • Bank of Montreal's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $172K in Q1 2018.
  • 37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.